EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

Similar documents
rare diseases research through National Plans and Strategies

The EU rare diseases policy framework: the context for ERNs

NORDIC CONFERENCE ON RARE DISEASES

Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

Pogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International Advisory Board

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer

the patients perspective and role of epags

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS

State of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report

Rare Cancer Perspective in the EUCERD

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

EUROPEAN REFERENCE NETWORKS and PERSPECTIVES for the FUTURE. H.Hintner Department of Dermatology Paracelsus Medical University Salzburg

Maltese Presidency of the Council of the European Union. Ministry for Health

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

COMMISSION OF THE EUROPEAN COMMUNITIES

National Clinical Programme for Rare Diseases Prof. Eileen Treacy April 7 th,

Volunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland

Table Of Content. European Rare Kidney Diseases Reference Network... 2 Summary... 3 Work Package... 9

STRATEGIC APPROACH & WORKPLAN 2007

14414/15 AF/evt 1 DG G 3 C

Retina International General Assembly Auckland, New Zealand

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

Deliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society

The basics a. Mission Statement (unchanged) eurordi s.org

3135th JUSTICE and HOME AFFAIRS Council meeting Brussels, 13 and 14 December 2011

2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

Council of the European Union Brussels, 28 October 2015 (OR. en)

Table Of Content. EURORDIS_FY Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7

Scientific Cooperation and Networking between EFSA and Member States

Harmonized Salt Iodization future policy approach to achieve the mission and vision in eliminating Iodine deficiency in Europe

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report

ENFSI ACTION PLAN. PERIOD: REF: BRD-FWK-009 ISSUE NO: 1 DATE: 30 June 2016

6078/16 LB/dk 1 DGD 1C

Enerca: The European Network for Patients with Rare Anaemias

Table Of Content. SSI_FY Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8

COMMISSION OF THE EUROPEAN COMMUNITIES

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report

A multi-stakeholder partnership initiative. 10 February 2012

Introduction. Legislation & Policy Context

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission

Table Of Content. Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners...

The Ayrshire Hospice

RARE-Bestpractices Project. Final Conference

Economic and Social Council

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks

Summary Report EU Health Award 2017

The Life Course Immunisation Initiative

15050/15 JS/pm 1 DGB 3B

TABLE of Contents. EURORDIS in brief

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE

Parma, 21/09/2015 SCIENTIFIC EVALUATION OF REGULATED PRODUCTS DEPARTMENT

EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

Title Corporate Parenting Plan

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

ECIBC overview. Donata LERDA Healthcare Quality Team leader

Peer counselling A new element in the ET2020 toolbox

Common Criteria. for. CGIAR Research Proposal (CRP) Design and Assessment

Towards Integrated Syndromic Surveillance in Europe?

Eurydice activities in the field of Early Childhood Education and Care (KD ECEC 2014)

Updated Activity Work Plan : Drug and Alcohol Treatment

South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member

HEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018

DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN

Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006

Healthy London Partnership - Prevention Programme Healthy Steps Together Expression of interest

Open Access Strategy of UNESCO

Briefing paper Horizon 2020 call SC1-PM Promoting mental health and well-being in the young

AUCKLAND REGIONAL ALCOHOL FORUM. 2 June 2011

A REVIEW OF NATIONAL CANCER CONTROL PLAN.? PROPOSALS FOR

Federation of EU Specialty Food Ingredients Industries

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Guideline on good pharmacovigilance practices (GVP)

PROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary

JPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance

Workshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation

Updates from the European Centre for Disease Prevention and Control

The European Reference Network in Rare Hematological Diseases

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013

CORPORATE PLANS FOR CHILD PROTECTION AND LOOKED ATER CHILDREN AND YOUNG PEOPLE

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

COU CIL OF THE EUROPEA U IO. Brussels, 27 July /09 ADD 2 SA 202 SOC 459 RECH 237 COVER OTE

London Regional Cancer Program

British Association of Stroke Physicians Strategy 2017 to 2020

SUMMARY OF INTERIM REPORT

2. The role of CCG lay members and non-executive directors

Table Of Content. Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

GOOD PHARMACOPOEIAL PRACTICES

DRAFT VERSION I SAFEGUARDING CHILDRENS BOARD MARCH 2017 SOUTHWARK PREVENT DRAFT LOCAL DELIVERY PLAN Page 1

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE

Primary Health Networks

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

ENYPAT European Network on Young People and Tobacco Final Report

REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN?

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Local Healthwatch Quality Statements. February 2016

Transcription:

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT

The need for European Reference Networks (ERNs) for rare diseases There are over 6 000 rare diseases The challenge of rarity : Patients are rare Experts are rare Centres of expertise are a means of: Revealing where expertise lies Gathering experience to improve knowledge and care

Previous EUCERD recommendation on centres of expertise (2011) To help MS in their reflections/ policy developments concerning national plans and strategies for RD Specifically in addressing the organisation of healthcare pathways at national and European level Necessary steps to build up ERNs

European context Development of ERNs in the field of RD encouraged explicitly in: Council Recommendation on an Action in the Field of RD (2009/C 151/02) (8 June 2009) Directive on the application of patients rights in cross-border healthcare (2011/24/EU) (9 March 2011)

ERNs in the Cross-Border Healthcare Directive Directive on the application of patients rights in cross-border healthcare (2011/24/EU) (9 March 2011) The Commission shall support Member States in the development of European reference networks between healthcare providers and centres of expertise in the Member States, in particular in the area of rare diseases Member States are encouraged to facilitate the development of the European reference networks: (a) by connecting appropriate healthcare providers and centres of expertise throughout their national territory and ensuring the dissemination of information towards appropriate healthcare providers and centres of expertise throughout their national territory; (b) by fostering the participation of healthcare providers and centres of expertise in the European reference networks.

ERNs in the Council Recommendation Council Recommendation on an Action in the Field of RD (2009/C 151/02) (8 June 2009) encourages MS to: Foster the participation of centres of expertise in European reference networks respecting the national competences and rules with regard to their authorisation or recognition

EUCERD RECOMMENDATIONS

Elaboration of the Recommendations Concepts defined by the High Level Group on Health Care & Medical Services (HLG) and by the Rare Disease Task Force (RDTF) Initial discussion at EUCERD in January 2012 Informal workshop and discussion at EUCERD plenary in June 2012 Workshop in September 2012 to work on draft recommendations Draft sent to EUCERD MS representatives for review prior to November 2012 meeting & rediscussed by EUCERD Final draft elaborated and sent to EUCERD for adoption Recommendations unanimously adopted at EUCERD meeting 31 January 2013

Aim of EUCERD recommendations Inform the Commission services and expert groups working on criteria for the creation and designation of ERNs in the context of the Cross-Border Healthcare Directive on specificities of RD Inform Member States who are developing their healthcare pathways at both the national and EU levels in the field of rare diseases above all in the context of national plans/strategies for rare diseases (recommended by end of 2013)

Structure of the Document Introduction Background to the Recommendations Scope of these Recommendations Target groups for these Recommendations Recommendations to the MS and the EC Mission, Vision and Scope Governance Composition of RD ERNs Funding and Evaluation Designation of RD ERNs Appendix

Target Groups for the Recommendations Member States European Commission Other EC initiatives (e.g. other projects and Joint Actions, Cross-Border Healthcare Expert Group, EUnetHTA, EPAAC) Centres of expertise in the field of RD Healthcare providers RD experts and existing RD network co-ordinators and partners Patient Organisations

Mission, scope and vision Mission of the ERNs Role of CEs Core tools and activities Mechanisms to ensure healthcare pathways for CEs and patients, including those with unclear diagnosis

Mission, Vision and Scope of RD ERNs ERNs provide framework for healthcare pathways for RD patients CEs are core participants in ERNs ERN to be flexible to work with different national CE structures

Mission, Vision and Scope of RD ERNs ERN to cover core tools and activities Registries quality assurance mechanisms for laboratory testing mechanism for information flow for good practice guidelines training/education tools mechanisms for evaluation/indicators of performance communications infrastructure cross-border referral mechanisms telemedicine core

Mission, Vision and Scope of RD ERNs ERNs provide guidance, definitions and mechanisms to ensure transparent/seamless healthcare pathways Models to provide such a mechanism for patients without a clear diagnosis should be explored ERNs should have capacity to follow patients with unclear diagnosis and manage their care according to medical need

Governance ERNs should have robust and clearly defined governance with oversight structures and comparable methods for evaluation ERNs require strong leadership: coordinating site should show proven ability to coordinate network and shared tools

Composition of RD ERNs RD ERNs to deliver added value in at least 3 of the objectives of Cross-Border Healthcare Directive, Art.12 Different forms of affiliation to ERNs to allow inclusivity Sharing knowledge: An overarching goal

Composition of RD ERNs Composed of existing CEs and future ones to enhance collaboration Due to the complexity of rare diseases, ERNs will link CEs and stakeholders involved in the care management of the patients: specialised health care providers specialised social care providers patient groups diagnostic laboratories relevant research groups

Funding and evaluation Financial system of CEs/ affiliated centres is a MS competence Funding for ERNs to support coordination and networking activities: needs to be adequate, long term: at least 5 years To be proportional to number of target patients, number of integrated centres, number of diseases covered specific costs for networking should be part of a sustainable funding mechanism from EC funds

Designation Before ERN designation, the development of shared platforms across RD ERNs should be considered Clear RD ERN designation process Stepwise-strategy for ERN designation so all RD patients will have access to appropriate ERN in a defined period of time

Designation As there will only be a limited number of RD ERNs, priority given to those: With existing formal/informal networks of experts With patient organisation cooperation With existing patient organisation networks With sufficient existing activities of research output

Designation Based around the concept of medical specialties and body systems, diagnostic and therapeutic areas can be identified, covering a wide range of diseases approximately 20-30 ERNs Goal: to be established by the end of the Health For Growth Programme in 2020

Designation Formal system for networking across all RD ERNs and sharing expertise should be defined and implemented Working groups to be established as necessary to oversee implementation of RD ERNs, acting ideally under EUCERD auspices

Next steps Presented to the Expert Group on Cross Border Healthcare in February 2013 for use in their work on ERNs EUCERD ready to collaborate further in the field of ERNs for RD in the context of the implementation of the Cross-Border Healthcare Directive

Thank you for your attention! The text of the recommendation can be found on the EUCERD s website

Key Documents (part 1) Directive (EC 2011/24/EU) of the European Parliament and of the Council on the application of patients' rights in cross-border health care EUCERD Recommendations on Quality Criteria for Centres of Expertise for Rare Diseases in Member States (24 October 2012) EURORDIS Position Paper European Reference Networks for Rare Diseases (May 2012) EUCERD Report: Preliminary analysis of the experiences and outcomes of ERNs for rare diseases (May 2011) Commission Communication, Rare Diseases Europe s Challenge Council Recommendation (2009/C 151/02) of 8 June on an action in the field of rare diseases Work of the High Level Group on Health Services and Medical Care during 2005

Key Documents (part 2) RDTF Report: Overview of Current Centres of Reference on rare diseases in the EU (September 2005) RDTF Report: Centres of Reference for Rare Diseases in Europe Stateof-the-art in 2006 and Recommendations of the Rare Diseases Task Force (September 2006) RDTF Report: European Reference Networks in the field of Rare Diseases: State of the art and Future Directions (July 2008) EUCERD Workshop Report: Centres of expertise and European Reference Networks for Rare Diseases (8-9/12/2010) EUCERD Workshop Report: National centres of expertise for rare diseases and networking between centres of expertise for rare diseases (21-22/03/2011) Eurordis Declaration of Common Principles on Centres of Expertise and European Reference Networks for Rare Diseases, 15 November 2008